IPP Bureau
Dr Reddy’s numbers in line; launches in FY23 likely drivers: ICICI Direct
By IPP Bureau - January 31, 2022
ICICI Direct analysis of Dr Reddy’s Q3FY22 results
USFDA approves Genentech’s Vabysmo to treat causes of vision loss
By IPP Bureau - January 31, 2022
Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
DRiefcase app for Ayushman Bharat Digital Mission
By IPP Bureau - January 31, 2022
ABDM is a digital framework that will connect patients, doctors and other healthcare stakeholders nationwide to facilitate safe and secure movement of health information
Granules Pharmaceuticals concludes USFDA audit with three minor observations
By IPP Bureau - January 31, 2022
The audit is a PAI for two of its product applications filed from this facility
Cipla has strong traction in India and the US: ICICI Direct
By IPP Bureau - January 31, 2022
ICICI Direct’s analysis of Cipla’s Q3FY22 results
Sun Pharma Q3FY22 PAT at Rs 2058.8 cr.
By IPP Bureau - January 31, 2022
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
Alkem enters exclusive license agreement with Johns Hopkins University
By IPP Bureau - January 31, 2022
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
Foreign Direct Investment in pharma grows at rapid pace: Eco Survey
By IPP Bureau - January 31, 2022
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Union Budget 2022-23 : Industry expects increased allocation to healthcare, skill development, R&D and universal health insurance
By IPP Bureau - January 30, 2022
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Union Budget 2022-23 : Medtech expects incentives, GST exemptions and custom duty rationalisation
By IPP Bureau - January 30, 2022
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
DCGI approves Bharat Biotech’s Phase 3 trials for intranasal vaccine
By IPP Bureau - January 29, 2022
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
Union minister Mansukh Mandaviya launches NIPER website
By IPP Bureau - January 29, 2022
The aim is to strengthen industry-academia cooperation
Sparsh hospital opens multi-organ transplant centre in Bengaluru
By IPP Bureau - January 29, 2022
The new centre will comprise a team of 50 highly experienced specialists
Israel signs deal to purchase Novavax’ Covid-19 vaccine
By IPP Bureau - January 29, 2022
It would be the first protein-based alternative available in Israel
ARVs bottom out while CRAMS growth continues for Laurus Labs: ICICI Direct
By IPP Bureau - January 29, 2022
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
